.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The metastatic process remains the primary cause of mortality in cancer patients. While hemostasis is their primary role, research now highlights how coagulation factors in metastasis act as architects of the pre-metastatic niche (PMN). These factors modify distant organs before tumor cells arrive. Therefore, clinicians can explore novel therapeutic avenues by understanding these mechanisms.
The formation of a PMN involves complex interactions between circulating elements and the microenvironment. Because factors like platelets, fibrinogen, and thrombin contribute to this preparation, they are critical targets. Platelets, for instance, release growth factors that trigger extracellular matrix remodeling. Furthermore, tissue factors activate endothelial cells. This activation increases vascular permeability. As a result, this environment allows circulating tumor cells to colonize distant tissues more effectively. Consequently, the PMN becomes a fertile ground for cancer spread.
Moreover, recognizing the role of coagulation factors in metastasis shifts our perspective on anti-thrombotic therapy. Clinical studies suggest that targeting these pathways could potentially stall cancer progression. For example, inhibiting thrombin or certain tissue factors might prevent immune cell recruitment. Additionally, this approach may reduce the overall metastatic burden in high-risk patients. In conclusion, the intersection of hematology and oncology offers promising directions for future treatments.
The PMN is a specialized environment in distant organs prepared by primary tumor factors and host cells. It supports the survival and growth of circulating tumor cells before they actually arrive at the site.
Platelets release various growth factors and cytokines that remodel the extracellular matrix. They also promote inflammation and shield tumor cells from immune system detection while in circulation.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Huang H et al. The unseen architects of metastasis: coagulation factors in pre-metastatic niche development. Cell Commun Signal. 2026 Feb 11. doi: 10.1186/s12964-026-02727-0. PMID: 41673656.
Perz JB et al. The Emerging Role of Platelets in the Formation of the Micrometastatic Niche. Front Oncol. 2020. doi: 10.3389/fonc.2020.00318.
Kasthuri RS et al. Role of Tissue Factor in Cancer. J Clin Oncol. 2009;27(21):3434-3441. doi: 10.1200/JCO.2009.22.6324.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of how coagulation factors like platelets and thrombin prepare distant organs for cancer metastasis, offering new targets for oncological therapy....
6 months ago
A comparative analysis shows that older age, elevated blood glucose, and abdominal adiposity are primary drivers of hypertension. Comprehensive evaluation of cardiometabolic risk profiles enables clinicians to detect overlapping metabolic dysfunctions early and optimize targeted prevention strategies.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Left ventricular thrombus is a severe complication of acute decompensated heart failure. This clinical review explores the pathophysiology, imaging challenges, and pharmacotherapeutic considerations of laminated thrombi, evaluating the evolving role of direct oral anticoagulants versus traditional warfarin.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
